Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.68
-0.05 (-0.36%)
Aug 26, 2026, 4:00 PM EDT - Market closed

Korro Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Revenue
2.383.846.397.376.284.822.27---------
Revenue Growth
-62.08%-20.31%181.46%-------------
Gross Profit
-41.02-44.33-48.74-52.44-55.36-55.22-50.04-86.13-73.04-58.76-48-----
Operating Income
-76.9-82.76-87.34-93.27-97.32-95.48-91.91-95.76-91.62-85.9-84.53-74.1-70.69-65.45-59-35.49
Net Income
-106.64-113.5-117.26-88.42-91.36-87.41-83.58-87.81-85.3-81.12-81.17-71.78-68.67-64.06-58.03-21.96
Earnings Per Share
-8.88-11.41-12.48-9.42-9.76-9.44-9.37-11.11-15.11-23.40-53.08-11.96-12.16-11.59-227.42-4.94
EPS Growth
----------------

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Cash & Investments
137.92157.0585.19102.49119.63138.99163.05169.11187.78138.8166.1546.1260.3379.5255.25118.53
Total Debt
42.2142.8943.4944.6744.6345.1944.7741.7938.4635.9233.2131.22292.443.13-
Net Cash (Debt)
95.71114.1741.757.8374.9993.81118.29127.33149.32102.89132.9414.931.3377.0952.12118.53
Net Cash Growth
27.62%21.70%-64.75%-54.58%-49.78%-8.83%-11.02%754.60%376.65%33.47%155.08%----56.03%-
Net Cash Per Share
7.9711.484.446.168.0110.1313.2616.1226.4629.6886.932.485.5513.95204.2426.65

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Operating Cash Flow
-67.95-70.18-78.56-68.35-67.27-62.64-60.07-73.69-69.36-69.49-67.28-61.21-63.7-60.54-53.65-32.09
Capital Expenditures
-0.32-0.42-0.52-1.89-6.59-12.41-17.9-18.11-13.47-11.93-7.84-7.59-9.01-5.5-5.21-4.45
Free Cash Flow
-68.27-70.6-79.08-70.24-73.86-75.05-77.98-91.79-82.84-81.42-75.12-68.8-72.71-66.04-58.86-36.54
Free Cash Flow Growth
----------------

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Operating Margin
-3228.34%-2154.03%-1366.43%-1265.31%-1549.45%-1980.44%-4047.12%---------
Pretax Margin
-4441.86%-2935.09%-1824.52%-1198.11%-1452.95%-1810.56%-3674.15%---------
Profit Margin
-4477.08%-2954.14%-1834.48%-1199.53%-1454.47%-1813.13%-3680.36%---------
FCF Margin
-2865.87%-1837.66%-1237.16%-952.92%-1175.91%-1556.63%-3433.55%---------

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
PS Ratio
79.8042.4911.8061.0118.6733.91157.04---------